Skip to main content

Remedios Rios Barrera

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca
Remedios Rios Barrera

Remedios Rios Barrera

Remedios Rios Barrera

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio.

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Remedios Rios Barrera, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Instituto de Salud Carlos III
Funding: 127500
Reference: PI23/00260
Duration: 01/01/2024 - 31/12/2027

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

Related professionals

Maria Antonia Perello Barcelo

Maria Antonia Perello Barcelo

Predoctoral researcher
Maternal and Fetal Medicine
Read more
Carmen Rodriguez Fernandez

Carmen Rodriguez Fernandez

Research technician
Ophtalmology
Read more
Patricia Muñoz Cabello

Patricia Muñoz Cabello

Predoctoral researcher
Genetics Medicine
Read more
Jaime Vega Costa

Jaime Vega Costa

Predoctoral researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.